[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 23, Issue 4 (Iranian South Medical Journal 2020) ::
Iran South Med J 2020, 23(4): 312-320 Back to browse issues page
The Efficacy of Autologous Plasma Therapy in Patients with Chronic Urticaria
Afshin Shirkani1 , Abbas Hadipour2, Afshin Ostovar3, Ali Movahed4, Safora Pordel1, Marjan Zamani1, Milad Shamshrikar1, Fatemeh Omrani1, Shokroolah Farrokhi 5
1- Department of Immunology, Asthma and Allergy, The Persian Gulf Tropical Medicine Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran
2- Department of Dermatology, The Persian Gulf Tropical Medicine Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran
3- Department of Epidemiology, The Persian Gulf Tropical Medicine Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran
4- Department of Biochemistry, The Persian Gulf Tropical Medicine Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran
5- Department of Immunology, Asthma and Allergy, The Persian Gulf Tropical Medicine Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran , sh.farokhi@bpums.ac.ir
Abstract:   (965 Views)
Background: Chronic urticaria is an allergic skin disease characterized by severe pruritic wheal persisting at least for 6 weeks. This study aimed to evaluate the efficacy of plasma therapy used for the first time for the treatment of idiopathic chronic urticaria.
Materials and Methods: In this case series study, the quality of life (QOL) of 30 patients with idiopathic chronic urticaria (autoimmune and spontaneous) referred to allergy clinic was evaluated before and after autologous plasma therapy by using standard questionnaires (DLQI and TSS).
Results: The findings showed that the means of DLQI and TSS scores in the patients after plasma therapy was significantly reduced. The findings showed that the means of TSS scores in the patients after plasma therapy was significantly reduced (p<0/001). Moreover, it was found that plasma therapy was significantly effective patients with idiopathic chronic urticaria (autoimmune and spontaneous) by using standard
questionnaires (TSS)(p=0.001). The findings showed that the means of DLQI  scores in the patients after plasma therapy was significantly reduced (p=<0.001) means of DLQI  scores in the women in contrast to men after plasma therapy was significantly reduced ( p=0.04) .This indicates that the improvement of the QOL in the patients. Moreover, it was found that plasma therapy was significantly effective in both sexes.
Conclusion: The results of the present study suggest that autologous plasma therapy could be a suitable method for the treatment of patients with idiopathic chronic urticaria.
Keywords: Chronic urticaria, Plasma therapy, DLQI and TSS scores, Quality of life
Full-Text [PDF 767 kb]   (183 Downloads)    
Type of Study: Original | Subject: Microbiology and Immunology
Received: 2020/01/19 | Accepted: 2020/05/3 | Published: 2020/09/30
References
1. Adkinson Jr NF, Bochner BS, Burks AW, et al. Middleton's Allergy: Principles And Practice. 8 th ed. Netherlands: Elsevier Health Sciences, 2013.
2. Greaves MW. Chronic Urticaria In Childhood. Allerg 2000; 55(4): 309-20. [DOI:10.1034/j.1398-9995.2000.00116.x]
3. Tang L, Hui K, LI C. EAACI/GA2LEN/EDF/WAO Guideline: Management Of Urticaria. Chinese J Dermatovenereol 2010; 9: 871-86.
4. Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA2LEN/EDF/WAO Guideline For The Definition, Classification, Diagnosis, And Management Of Urticaria: The 2013 Revision And Update. Allergy 2014; 69(7): 868-87. [DOI:10.1111/all.12313]
5. Alpay A, Solak Tekin N, Tekin IÖ, et al. Autologous Serum Skin Test Versus Autologous Plasma Skin Test In Patients With Chronic Spontaneous Urticaria. Dermatol Res Pract 2013; 2013: 267278. [DOI:10.1155/2013/267278]
6. Sánchez-Borges M, Asero R, Ansotegui IJ, et al. Diagnosis And Treatment Of Urticaria And Angioedema: A Worldwide Perspective. World Allergy Organ J 2012; 5(11): 125-47. [DOI:10.1097/WOX.0b013e3182758d6c]
7. Bernstein JA, Lang DM, Khan DA, et al. The Diagnosis And Management Of Acute And Chronic Urticaria: 2014 Update. J Allergy Clin Immunol 2014; 133(5): 1270-7. [DOI:10.1016/j.jaci.2014.02.036]
8. Greenberger PA. Chronic Urticaria: New Management Options. World Allergy Organ J 2014; 7(1): 31. [DOI:10.1186/1939-4551-7-31]
9. Ward PA, Hill JH. C5 Chemotactic Fragments Produced By An Enzyme In Lysosomal Granules Of Neutrophils. J Immunol 1970; 104(3): 535-43.
10. Sabroe RA, Grattan CE, Francis DM, et al. The Autologous Serum Skin Test: A Screening Test For Autoantibodies In Chronic Idiopathic Urticaria. Br J Dermatol 1999; 140(3): 446-52. [DOI:10.1046/j.1365-2133.1999.02707.x]
11. Poonawalla T, Kelly B. Urticaria : A Review. Am J Clin Dermatol 2009; 10(1): 9-21. [DOI:10.2165/0128071-200910010-00002]
12. Grob JJ, Revuz J, Ortonne JP, et al. Comparative Study Of The Impact Of Chronic Urticaria, Psoriasis And Atopic Dermatitis On The Quality Of Life. Br J Dermatol 2005; 152(2): 289-95. [DOI:10.1111/j.1365-2133.2005.06385.x]
13. O'donnell B, Lawlor F, Simpson J, et al. The Impact Of Chronic Urticaria On The Quality Of Life. Br J Dermatol 1997; 136(2): 197-201. [DOI:10.1046/j.1365-2133.1997.d01-1168.x]
14. Alvarado‐ Flores E, Avalos‐ Díaz E, Diaz LA, et al. Anti‐ Idiotype Antibodies Neutralize In Vivo The Blistering Effect Of Pemphigus Foliaceus IgG. Scand J Immunol 2001; 53(3): 254-8. [DOI:10.1046/j.1365-3083.2001.00863.x]
15. Farrokhi Sh, Gheybi MK, Movahed A, et al. Evaluation Of The Frequency Of Food And Aeroallergens In Patients With Eczema And Urticaria In Province Of Bushehr: Based On Skin Prick Test Reactivity. Iran South Med J 2014; 17(4): 629-37. (Persian)
16. Sabroe RA, Seed PT, Francis DM, et al. Chronic Idiopathic Urticaria: Comparison Of The Clinical Features Of Patients With And Without Anti-Fcϵri Or Anti-Ige Autoantibodies. J Am Acad Dermatol 1999; 40(3): 443-50. [DOI:10.1016/S0190-9622(99)70495-0]
17. Zuberbier T, Asero R, Bindslev‐ Jensen C, et al. EAACI/GA²LEN/EDF/WAO Guideline: Management Of Urticaria. Allergy 2009; 64(10): 1427-43. [DOI:10.1111/j.1398-9995.2009.02178.x]
18. Bajaj AK, Saraswat A, Upadhyay A, et al. Autologous Serum Therapy In Chronic Urticaria: Old Wine In A New Bottle. Indian J Dermatol Venereol Leprol 2008; 74(2): 109-13. [DOI:10.4103/0378-6323.39691]
19. Abdallah MA, Elzamk M, Sallam MA. Autologous Serum Injection Versus Autologous Blood In The Treatment Of Chronic Autoreactive Urticaria. J Egypt Womens Dermatol Soc 2012; 9(1): 26-31. [DOI:10.1097/01.EWX.0000407617.33366.0f]
20. Abolnezhadian F, Alyasin S, Amin R, et al. The Effect Of Autologous Serum Therapy On Disease Severity In Patients With Chronic Urticaria. Iran J Allergy Asthma Immunol 2016; 15(4): 328-33.
21. Piconi S, Trabattoni D, Iemoli E, et al. Immune Profiles Of Patients With Chronic Idiopathic Urticaria. Int Arch Of Allergy Immunol 2002; 128(1): 59-66. [DOI:10.1159/000058004]
22. Patil S, Sharma N, Godse K. Autologous Serum Therapy In Chronic Urticaria. Indian J Dermatol 2013; 58(3): 225-6. [DOI:10.4103/0019-5154.110833]
23. Staubach P, Onnen K, Vonend A, et al. Autologous Whole Blood Injections To Patients With Chronic Urticaria And A Positive Autologous Serum Skin Test: A PlaceboControlled Trial. Dermatology 2006; 212(2): 150-9. [DOI:10.1159/000090656]
24. Ferrer M. Epidemiology, Healthcare, Resources, Use And Clinical Features Of Different Types Of Urticaria. Alergológica 2005. J Investig Allergol Clin Immunol 2009; 19(Suppl 2): 21-6.
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Shirkani A, Hadipour A, Ostovar A, Movahed A, Pordel S, Zamani M, et al . The Efficacy of Autologous Plasma Therapy in Patients with Chronic Urticaria. Iran South Med J. 2020; 23 (4) :312-320
URL: http://ismj.bpums.ac.ir/article-1-1330-en.html


Volume 23, Issue 4 (Iranian South Medical Journal 2020) Back to browse issues page
دانشگاه علوم پزشکی بوشهر، طب جنوب ISMJ

Iranian South Medical Journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License which allows users to read,
copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly

Copyright © 2017, Iranian South Medical Journal| All Rights Reserved

Persian site map - English site map - Created in 0.04 seconds with 30 queries by YEKTAWEB 4313